Background: Today, the screening of fetal abnormalities during pregnancy is used as one of the components of the prenatal care worldwide, and many abnormalities are detected by ultrasound during pregnancy. On the other hand, the possibility of an abnormality in the fetus causes worry and anxiety in pregnant women. Therefore, the present study was conducted with the aim of determining the relationship between worry and anxiety with the general health status of pregnant women at risk of diagnosing fetal abnormalities.
View Article and Find Full Text PDFObjectives: Postpartum hemorrhage is a leading cause of maternal mortality worldwide. Emerging evidence suggests that the sumac plant possesses astringent and anti-inflammatory properties that may help reduce menstrual bleeding. Therefore, this study aimed to determine the effect of sumac capsules on postpartum bleeding among women at risk of excessive bleeding.
View Article and Find Full Text PDFThe use of biocompatible metal-organic frameworks (MOFs) and electrospun nanofibrous implants shows promise in preventing the recurrence of postsurgical glioblastoma. In this study, temozolomide (TMZ) and platinum‑gold nanorods (PtAu NRs) were encapsulated into the UiO-66-NH MOFs. These were then incorporated into the chitosan-grafted polycaprolactone (PCL) (core)/PCL (shell) nanofibers coated with PtAu NRs for extended release of TMZ during chemo-photothermal therapy against glioblastoma cells.
View Article and Find Full Text PDFSuper-resolution imaging is a powerful tool in modern biological research, allowing for the optical observation of subcellular structures with great detail. In this paper, we present a deep learning approach for image fusion of intensity and super-resolution optical fluctuation imaging (SOFI) microscopy images. We construct a network that can successfully combine the advantages of these two imaging methods, producing a fused image with a resolution comparable to that of SOFI and an SNR comparable to that of the intensity image.
View Article and Find Full Text PDFEtrasimod is a sphingosine 1 phosphate (S1P) receptor modulator approved for the treatment of moderate to severely active ulcerative colitis (UC). Etrasimod selectively activates S1P receptors with no detectable activity on S1P. The ELEVATE clinical trials evaluated the efficacy and safety of etrasimod for UC.
View Article and Find Full Text PDF